Bob Dudley | Founder, President and CEO |
Ric Peterson | CFO |
Frank Jaeger | Chief Commercial Officer |
Thank you for joining in the Clarus First Quarter 2022 Financial and Operating Results Conference Call. Today's call is being recorded and webcast live on the company's website at www.clarustherapeutics.com in the Investor Relations section, and it will be available for replay for 10 days following this live call. Please note that discussions today may include forward-looking statements. These forward-looking statements include statements regarding the market opportunity for JATENZO, the anticipated benefits of recent patient initiatives, and statements regarding the Clarus growth strategy, it's pipeline and IP portfolio among others.
Forward-looking statements involve a number of risks, uncertainties, some of which are beyond Clarus control.